Xenon Pharmaceuticals (XENE)
(Delayed Data from NSDQ)
$41.01 USD
+0.64 (1.59%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $41.02 +0.01 (0.02%) 7:46 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Earnings News For XENE
-
Xenon Pharmaceuticals: Q2 Earnings Snapshot
-
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
-
Xenon Pharmaceuticals: Q1 Earnings Snapshot
-
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Xenon (XENE) Q4 Earnings Top Estimates, Pipeline in Focus
-
Xenon Pharmaceuticals: Q4 Earnings Snapshot
-
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
Xenon Pharmaceuticals: Q3 Earnings Snapshot
-
Xenon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
Xenon Pharmaceuticals (XENE) Reports Q2 Loss, Misses Revenue Estimates
-
Xenon Pharmaceuticals: Q2 Earnings Snapshot
-
Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
Xenon Pharmaceuticals (XENE) Reports Q1 Loss, Lags Revenue Estimates
-
Xenon Pharmaceuticals: Q1 Earnings Snapshot
-
Xenon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
Xenon Pharmaceuticals (XENE) Expected to Beat Earnings Estimates: Should You Buy?
-
Xenon Pharmaceuticals (XENE) Reports Q4 Loss, Lags Revenue Estimates
-
Xenon Pharmaceuticals: Q4 Earnings Snapshot
-
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
-
Xenon Pharmaceuticals (XENE) Reports Q3 Loss, Misses Revenue Estimates
-
Xenon Pharmaceuticals: Q3 Earnings Snapshot
-
Xenon Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
Xenon Pharmaceuticals (XENE) Reports Q2 Loss, Misses Revenue Estimates
-
Xenon Pharmaceuticals: Q2 Earnings Snapshot
-
Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update